Stella Diagnostics (Stella Diagnostics) EV-to-EBIT : (As of May. 16, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Stella Diagnostics's Enterprise Value is $26.23 Mil. Stella Diagnostics does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's EV-to-EBIT at this moment.

The historical rank and industry rank for Stella Diagnostics's EV-to-EBIT or its related term are showing as below:

SLDX' s EV-to-EBIT Range Over the Past 10 Years
Min: -65.47 Med: 0 Max: 0
Current: -33.76

SLDX's EV-to-EBIT is ranked worse than
100% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 22.47 vs SLDX: -33.76

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Stella Diagnostics's Enterprise Value for the quarter that ended in Sep. 2023 was $45.51 Mil. Stella Diagnostics does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in Sep. 2023. Therefore, GuruFocus does not calculate Stella Diagnostics's Earnings Yield (Joel Greenblatt) % at this moment.

Stella Diagnostics EV-to-EBIT Historical Data

The historical data trend for Stella Diagnostics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics EV-to-EBIT Chart

Stella Diagnostics Annual Data

Trend

EV-to-EBIT

Stella Diagnostics Quarterly Data
	Sep22	Sep23
EV-to-EBIT	-	-

Competitive Comparison of Stella Diagnostics's EV-to-EBIT

For the Diagnostics & Research subindustry, Stella Diagnostics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stella Diagnostics's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Stella Diagnostics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Stella Diagnostics's EV-to-EBIT falls into.

Stella Diagnostics EV-to-EBIT Calculation

Stella Diagnostics's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	26.232	/
	=

Stella Diagnostics (OTCPK:SLDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Stella Diagnostics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=		/	45.509
	=	%

Stella Diagnostics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.